Metabolic Syndrome in Patients with Non-alcoholic Fatty Liver Disease: A Community Based Cross-sectional study.
metabolic syndrome
non-alcoholic fatty liver disease
obesity
waist circumference
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
19 Feb 2019
19 Feb 2019
Historique:
entrez:
7
5
2019
pubmed:
7
5
2019
medline:
7
5
2019
Statut:
epublish
Résumé
Background Non-alcoholic fatty liver disease (NAFLD) is the deposition of fat inside liver cells in the absence of secondary causes. It is considered as a hepatic complication of metabolic syndrome. The metabolic syndrome consists of dyslipidemia, hypertension, diabetes, and obesity. This study aims to determine the prevalence of metabolic syndrome in Nepalese patients with NAFLD from mid-Western part of Nepal. Method This was a descriptive cross-sectional study. Three different sites were chosen in and around Butwal sub-metropolitan city of Rupandehi district, Nepal. A one-day health camp for the screening of fatty liver disease by ultrasonography (USG) was conducted at these sites. Participants with fatty liver were then classified into three grades by USG and the presence of metabolic syndrome was assessed by the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATPIII) criteria. Results A total of 385 participants with NAFLD were evaluated. Presence of metabolic syndrome by NCEP-ATPIII criteria was found to be in 57.6% participants; whereas, at least one component of metabolic syndrome was found in 91.4% of participants with radiologic features of fatty liver. Higher proportion of patients with NAFLD were males. Increased waist circumference followed by low high-density lipoprotein (HDL) level were the most common components of metabolic syndrome in participants with NAFLD. Conclusions Metabolic syndrome is common in Nepalese community patients with NAFLD.
Identifiants
pubmed: 31057993
doi: 10.7759/cureus.4099
pmc: PMC6476620
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e4099Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
N Engl J Med. 2002 Apr 18;346(16):1221-31
pubmed: 11961152
Gastroenterology. 2002 Sep;123(3):745-50
pubmed: 12198701
Hepatology. 2003 Apr;37(4):917-23
pubmed: 12668987
Korean J Hepatol. 2004 Sep;10(3):197-206
pubmed: 15385714
Circulation. 2005 Oct 25;112(17):2735-52
pubmed: 16157765
J Hepatol. 2006 Jun;44(6):1196-207
pubmed: 16618516
Hippokratia. 2009 Jan;13(1):9-19
pubmed: 19240815
World J Gastroenterol. 2014 Oct 21;20(39):14185-204
pubmed: 25339806
J Lifestyle Med. 2015 Mar;5(1):7-13
pubmed: 26528424
Middle East J Dig Dis. 2016 Apr;8(2):131-7
pubmed: 27252820
Liver Int. 2017 Jan;37 Suppl 1:81-84
pubmed: 28052624
Clin Liver Dis. 2018 Feb;22(1):133-140
pubmed: 29128053
Diabetes Metab Syndr. 2018 Jul;12(4):569-575
pubmed: 29571977
Medicine (Baltimore). 2018 Mar;97(13):e0214
pubmed: 29595666
Front Neurosci. 2018 Apr 20;12:196
pubmed: 29731703
BMC Gastroenterol. 2018 Jul 6;18(1):109
pubmed: 29980170